RETRACTED ARTICLE: Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials Amir GhaderiAnna BussuSadegh Jafarnejad Review 16 November 2018 Pages: 289 - 301
Efficacy of vitamin C for the prevention and treatment of upper respiratory tract infection. A meta-analysis in children Philippe VorilhonBastien ArpajouAurélie Cabaillot Review 21 November 2018 Pages: 303 - 311
Non randomized study on the potential of nitisinone to inhibit cytochrome P450 2C9, 2D6, 2E1 and the organic anion transporters OAT1 and OAT3 in healthy volunteers Gunilla HuledalBirgitta OlssonAnders Bröijersén Clinical Trial Open access 15 November 2018 Pages: 313 - 320
Association between activated partial thromboplastin time, age and bleeding events in NVAF patients receiving dabigatran Qiuyi JiQing XuQianzhou Lv Clinical Trial 30 October 2018 Pages: 321 - 328
Efficacy and safety of BRAF inhibitors and anti-CTLA4 antibody in melanoma patients—real-world data Marta PolkowskaPaweł Ekk-CierniakowskiMałgorzata Kozłowska-Wojciechowska Clinical Trial 01 November 2018 Pages: 329 - 334
Do clinical and laboratory parameters predict thiopurine metabolism and clinical outcome in patients with inflammatory bowel diseases? Sven FrickDaniel MüllerAlexander Jetter Pharmacodynamics 04 January 2019 Pages: 335 - 342
The impact of R353Q genetic polymorphism in coagulation factor VII on the initial anticoagulant effect exerted by warfarin Chanan ShaulSimcha BlotnickYoseph Caraco Pharmacogenetics 09 November 2018 Pages: 343 - 350
Effects of magnesium oxide on pharmacokinetics of L-dopa/carbidopa and assessment of pharmacodynamic changes by a model-based simulation Yushi KashiharaYui TeraoIchiro Ieiri Pharmacokinetics and Disposition 31 October 2018 Pages: 351 - 361
Prediction of mizoribine pharmacokinetic parameters by serum creatinine in renal transplant recipients Pan ChenXuan XuChangxi Wang Pharmacokinetics and Disposition 01 November 2018 Pages: 363 - 369
Pharmacokinetics of free and total mycophenolic acid in adult lupus nephritis patients—implications for therapeutic drug monitoring Paulina ŁuszczyńskaTomasz PawińskiMagdalena Hurkacz Pharmacokinetics and Disposition Open access 14 November 2018 Pages: 371 - 379
Population pharmacokinetics of oxcarbazepine active metabolite in Chinese paediatric epilepsy patients and its application in individualised dosage regimens Wei-wei LinXi-wen LiChang-lian Wang Pharmacokinetics and Disposition 19 November 2018 Pages: 381 - 392
Selective serotonin re-uptake inhibitors and the risk of violent suicide: a nationwide postmortem study Jonas ForsmanThomas MastermanAnna Karin Hedström Pharmacoepidemiology and Prescription Open access 03 November 2018 Pages: 393 - 400
A population-based study of transdermal fentanyl initiation in Australian clinical practice Natasa GisevSallie-Anne PearsonLouisa Degenhardt Pharmacoepidemiology and Prescription 03 November 2018 Pages: 401 - 408
Statin-associated immune-mediated necrotizing myopathy: a retrospective analysis of individual case safety reports from VigiBase Dirk EssersMartina SchäublinStefan Weiler Pharmacoepidemiology and Prescription 15 November 2018 Pages: 409 - 416
Duration of new antidepressant use and factors associated with discontinuation among community-dwelling persons with Alzheimer’s disease Reetta KettunenHeidi TaipaleMarjaana Koponen Pharmacoepidemiology and Prescription Open access 09 November 2018 Pages: 417 - 425
Deprescribing in multi-morbid older people with polypharmacy: agreement between STOPPFrail explicit criteria and gold standard deprescribing using 100 standardized clinical cases Denis CurtinTim DukelowPaul Gallagher Pharmacoepidemiology and Prescription 12 November 2018 Pages: 427 - 432
Applying DoTS adverse drug reactions classification to reports from hospital stimulated reporting Andreea FarcasNoemi Beatrix BulikCristina Mogosan Letter to the Editor 10 November 2018 Pages: 433 - 435